Clinical Trials Sponsored by Thorsten Rudroff

Total 65 results

Thorsten Rudroff

Terminated

Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis

Multiple Sclerosis | Neuropathic Pain

United States
Thorsten Rudroff

Completed

Transcranial Direct Current Stimulation and Walking in Multiple Sclerosis

Transcranial Direct Current Stimulation

United States
Thorsten Rudroff

Completed

Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease

Parkinson Disease | Brain Stimulation | Cerebellum

United States
Thorsten Rudroff

Completed

Cannabis and Aging

Cannabis Use

United States
Thorsten Gruenheid

Completed

Transfer Accuracy of 3D-printed Indirect Bonding Trays

Dental Bonding

United States
Abbott Medical Devices
Thoratec Corporation; Thoratec Europe Ltd

Completed

HeartMate 3 ELEVATE™ Registry (ELEVATE™)

Heart Failure | Cardiovascular Disease | Ventricular Dysfunction

Italy, United Kingdom, Denmark, Germany, Singapore, Czechia, Kazakhstan, Netherlands, Austria, Israel, Poland
Rudolf Foundation Clinic

Unknown

Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration

Age-related Macular Degeneration

Austria
Rudolf Foundation Clinic

Unknown

Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population

Age-Related Macular Degeneration

Austria
Rudolf Foundation Clinic

Completed

The ROVO Study: Radial Optic Neurotomy for CVO

Central Retinal Vein Occlusion

Austria
Abbott Medical Devices
Thoratec Corporation

Completed

PREVENtion of HeartMate II Pump Thrombosis (PREVENT)

HeartMate II Pump Thrombosis

United States
Abbott Medical Devices
Thoratec Corporation

Completed

Driveline Silicone Skin Interface Registry (SSI)

Driveline Heart-assisted Device Related Infection

United States
Rudolf Foundation Clinic

Unknown

Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration

Age-Related Macular Degeneration

Austria
Rudolf Foundation Clinic

Completed

Retaane® in Age-Related Macular Degeneration

Age Related Macular Degeneration
Abbott Medical Devices
Thoratec Corporation

Completed

CentriMag RVAS U.S. Post-approval Study Protocol (CMagRVAS)

Right Ventricular Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management (ROADMAP)

Heart Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

HeartMate 3™ LIS Study (HM 3 LIS)

Heart Failure | Cardiovascular Disease

Germany, Czechia
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study (RESIST)

Left Ventricular Assist Device | Percutaneous Lead Management

United States
Abbott Medical Devices
Thoratec Corporation

Withdrawn

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass for Pediatric Patients

Heart Failure
University Hospital, Toulouse
Thoratec Corporation

Withdrawn

Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device (MESAD)

Chronic Myocardial Ischemia

France
Rebecca Thornton

Completed

Information About HIV Transmission and Circumcision on Subsequent Sexual Behavior, and the Demand for Circumcision

Sexual Behavior | Dis-inhibition
Abbott Medical Devices
Thoratec Europe Ltd

Completed

Screening for Advanced Heart Failure Treatment (SEE-HF) (SEE-HF)

Advanced Heart Failure | CRT and/or ICD

Netherlands, Sweden, Denmark, France, Germany, United Kingdom
Sarah Thordsen
Medical College of Wisconsin

Completed

"Treatment Use of ECMO In Pregnancy or Peripartum Patient."

Cardiogenic Shock | Peripartum Cardiomyopathy | Complication, Pregnancy

United States
Vanderbilt University Medical Center
Thoratec Corporation

Completed

Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).

Heart Failure

United States
University of Nebraska
Thoratec Corporation

Completed

Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study

Right Ventricular Dysfunction | End Stage Heart Disease

United States
Abbott Medical Devices
Thoratec Corporation

Terminated

Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

Cardiogenic Shock

Hungary, Germany, Czechia, Netherlands
Abbott Medical Devices
Thoratec Corporation

Completed

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

Heart Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy

Cardiomyopathies | Ventricular Dysfunction | Heart Failure, Congestive

United States, Canada
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Cardiomyopathies | Ventricular Dysfunction | Heart Failure, Congestive

United States, Canada
Abbott Medical Devices
Thoratec Corporation

Completed

MOMENTUM 3 IDE Clinical Study Protocol (HM3™)

Advanced Refractory Left Ventricular Heart Failure

United States
University of Louisville
Thoratec Corporation

Unknown

Remission From Stage D Heart Failure (RESTAGE-HF)

Heart Failure NYHA Class III | Heart Failure NYHA Class IV

United States
Rudolf Wuethrich

Completed

Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients (POSTOP)

Chronic Kidney Disease | Osteoporosis

Switzerland
Sarah Thordsen
Medical College of Wisconsin

Withdrawn

Diastolic Dysfunction PPCM in Patients With Documented Left Ventricular Systolic Function Recovery

Diastolic Dysfunction | Peripartum Cardiomyopathy

United States
Baylor College of Medicine
Thoratec Corporation

Completed

The IMPULSE Study: Pilot (IMPULSE)

Chronic Heart Failure

United States
Virginia Commonwealth University
Novartis; Thoratec Corporation

Completed

Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)

Gastrointestinal Bleeding

United States
Prof. Dr. Thorsten Staake
University of Turku

Completed

Handy Hygiene of Children: Understanding the Effect of Live Feedback on Handwashing Behavior

Hand Hygiene | Handwashing

Finland, Germany
Rennes University Hospital
Thoratec Europe Ltd

Withdrawn

LVAD in Non Cardiac Transplant Candidates and Non Responders to Resynchronization (CHECKMATE)

Heart Failure at NYHA Stage III or IV | Non Responders to Resynchronization | Non Candidates for Transplantation

France, Germany
Abbott Medical Devices
Thoratec Europe Ltd

Completed

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE) (TRACE)

Anticoagulation | Left Ventricular Assist Device

United States, Austria, France, Germany, Czechia
Kristiania University College
Horten municipality

Active, not recruiting

HOPPLearning - Active Learning in Elementary Schools (HOPPLearning)

Health Behaviour

Norway
Rudolf Uher

Recruiting

Treatment Interrupts Depression Early (TIDE)

Depression

Canada
Rudolf Berger

Unknown

Performance of Bioabsorbable Vascular Scaffolds (Absorb) Compared to Xience Stents - an Optical Coherence Tomography Study

Bioresorbable Scaffolds

Austria
PD Dr. med. Thorsten Mikoteit
Psychiatrische Dienste Solothurn; Privatklinik Wyss

Recruiting

Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy (PrePGx)

Depression

Switzerland
Peter Korsten
DiaMed GmbH

Recruiting

Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis (RHEACT)

Systemic Sclerosis | Scleroderma | Raynaud Phenomenon | Digital Ulcer

Germany
Kristina Tedroff
Karolinska University Hospital; Danderyd Hospital

Terminated

Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial (BATCP)

Pain | Cerebral Palsy, Spastic

Sweden
UMC Utrecht
Rudolf Magnus Institute - University of Utrecht

Unknown

A New Method for Delineation of Epileptic Brian Tissue During Epilepsy Surgery (The HFO Study)

Refractory Localization-related Epilepsy

Netherlands
Simon Francis Thomsen
Aarhus University Hospital

Recruiting

Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria (EXOTIC)

Chronic Spontaneous Urticaria | Chronic Urticaria, Idiopathic

Denmark
Jakob Louis Thomsen
Merck Sharp & Dohme LLC

Completed

Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals

Neuromuscular Blockade

Denmark
amy tiersten
Novartis

Active, not recruiting

Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer

Breast Cancer

United States
amy tiersten
AstraZeneca; Eisai Inc.

Completed

Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer

Recurrent Ovarian Cancer | HER2-Negative Metastatic Breast Cancer

United States
Abbott Medical Devices
Thoratec Corporation; KCRI; Center for Life Sciences; Emergo

Completed

HeartMate 3™ CE Mark Clinical Investigation Plan (HM3 CE Mark)

Advanced Refractory Left Ventricular Heart Failure

Germany, Australia, Austria, Canada, Czechia, Kazakhstan
Abbott Medical Devices
KU Leuven; Thoratec Corporation; Cliniques universitaires Saint-Luc- Université... and other collaborators

Completed

BeneMACS Study:HeartMate 2 (HM2)Left Ventricular Assist Device (LVAD) Survival in Non Transplant Patients is Equal/Better Than Results in Medical Literature (BeneMACs)

Heart Failure

Belgium

Clinical Trials Sponsored by Thorsten Rudroff

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations